Advanced Filters
noise
Found 65,447 clinical trials
N Natalie Goedeker

Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients

Phase 2a trial of SAT-3247 in ambulatory DMD patients aged ≥ 7 and \< 10 years. The trial will study two doses of SAT-3247 in a randomized, double-blind, placebo-controlled weekday regimen for 12 weeks to determine the optimal dose, safety, tolerability, and preliminary efficacy.

7 - 9 years of age Male Phase 2
M Muhmmad Asif Javed, MS

Effects of Modified CIMT With and Without PNF

This randomized clinical trial investigates the effects of modified CIMT with and without the addition of PNF techniques on upper extremity function in pediatric stroke patients, aiming to determine whether combining these approaches yields superior motor recovery.This study will be conducted as a randomized clinical trial over an intervention period …

5 - 13 years of age All Phase N/A
K Klaus Witte

The Force Frequency Relationship in Heart Failure and Diabetes Mellitus: a Metabolic Aetiology?

The present investigation is a non-randomised, observational study involving an unselected but highly phenotyped cohort of patients undergoing pacemaker or defibrillator implantation from whom a small sample of fat and muscle will be taken from the operation site, and, in a subgroup, from the thigh muscle. A sample of blood …

18 years of age All Phase N/A
Y Yingying Du

A Phase Ⅰ/Ⅱa Study of HMPL-A251 in Participants With Advanced or Metastatic HER2-expressing Solid Tumors

This is a first-in-human (FIH), phase Ⅰ/Ⅱa, open-label, multicenter clinical study of HMPL-A251 monotherapy in adult participants with unresectable, advanced or metastatic HER2-expressing solid tumors.

18 years of age All Phase 1/2
R Ruben Visch, M.D.

Obinutuzumab Induced Decreases of PLA2R Antibodies in Membranous Nephropathy: a Pilot Study

Objective: To assess the disappearance rate (half-life) of anti-PLA2R antibodies in high-risk primary membranous nephropathy (pMN) patients treated with obinutuzumab (OBI), and to evaluate immunological and clinical remission, adverse events, and quality of life. Design: Open-label, single-center, prospective pilot intervention study conducted at Radboud University Medical Center. Population: 20 adult …

18 years of age All Phase 2/3
T Tugce Dinc

Assessment of Preoperative Anxiety and Evaluation of Calming Interventions: Anonymous Patient Survey

The aim of this study is to better understand the anxiety of patients before elective surgeries and to investigate which measures for calming are perceived as helpful or pleasant. Adult, German-speaking patients (≥18 years) in the elective surgical setting at UKB are invited to participate. It is planned that at …

18 years of age All Phase N/A
M Mónica Cebrián Coordinator Clinical Research Area

Validation of the Sentinel Lymph Node Technique in Early-stage Ovarian Cancer (SENTOV II)

This clinical trial investigates the sentinel lymph node (SLN) technique as a less invasive alternative to conventional lymphadenectomy in patients with early-stage ovarian cancer. The primary objective is to evaluate the effectiveness, safety, and diagnostic accuracy of the SLN approach in detecting lymphatic metastases. By assessing its negative predictive value, …

18 years of age Female Phase 3

Breast Cancer and Chemobrain : Effects of Photobiomodulation on the Improvement of Perceived Cognitive Impairment

Breast cancer is one of the most common cancers in metropolitan France, with over 60,000 new cases in 2023. Mostly a female cancer, it can affect a young population, with around 20% of breast cancers occurring in women under 50. Treatment is mainly based on surgery, chemotherapy, radiotherapy, targeted therapies …

years of age Female Phase N/A
D Dongsheng Fan

The Safety, Tolerability and Preliminary Efficacy of Derived Motor Neuron Progenitor Cells (XS228CN) in Subjects With Amyotrophic Lateral Sclerosis

A Phase I Study to Assess the Safety, Tolerability and Preliminary Efficacy of Derived Motor Neuron Progenitor Cells (XS228CN) in Subjects with Amyotrophic Lateral Sclerosis

18 - 75 years of age All Phase 1
M Matthew Amsden

Evaluating Heart & Soil's Whole Package on Men's Health

This study explores how Heart \& Soil's Whole Package impacts men's hormone health, strength, and virility using blood testosterone tracking and self-reported measures.

18 years of age Male Phase N/A

Simplify language using AI